Replimune to Present at the 42nd Annual J.P. Morgan Healthcare Conference
WOBURN, Mass., Dec. 28, 2023 (GLOBE NEWSWIRE) — Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the […]
Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Myriam J. Curet, M.D. to its Board of Directors
MINNEAPOLIS, Dec. 28, 2023 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on […]
TSX News -
AGF Investments Announces Final Distributions for AGF Investments ETFs for 2023
TORONTO, Dec. 28, 2023 (GLOBE NEWSWIRE) — AGF Investments Inc. (AGF Investments ) today announced the final December 2023 cash […]
TSX News -
Northland Power and Gentari Renewables Announce Closing of Hai Long Partnership
TORONTO, Dec. 28, 2023 (GLOBE NEWSWIRE) — Northland Power Inc. (“Northland” or the “Company”) (TSX: NPI) today announced the closing […]
TSX News -
Mattr Receives Over $27 Million in International Purchase Orders for Flexpipe
TORONTO, Dec. 28, 2023 (GLOBE NEWSWIRE) — Shawcor Ltd., dba Mattr Infratech (“Mattr” or the “Company”) (TSX: MATR) announced today […]
Fireweed Provides Year-End Review of Record-Setting 2023 Accomplishments
VANCOUVER, British Columbia, Dec. 28, 2023 (GLOBE NEWSWIRE) — FIREWEED METALS CORP. (“Fireweed” or the “Company”) (TSXV: FWZ; OTCQB: FWEDF; […]
Revival Gold 2023 Year in Review
TORONTO, Dec. 28, 2023 (GLOBE NEWSWIRE) — Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) (“Revival Gold” or the “Company”) is […]
MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for the U.S. Army
YAVNE, Israel, Dec. 28, 2023 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generation enzymatic […]
SEALSQ’s Post-Quantum Semiconductor Technology Fortifies Cryptocurrency Security
Tortola, British Virgin Islands, Dec. 28, 2023 (GLOBE NEWSWIRE) — December 28, 2023: SEALSQ Corp (“SEALSQ” or “Company”) (NASDAQ: LAES), […]
CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation
PRINCETON, N.J., Dec. 28, 2023 (GLOBE NEWSWIRE) — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions […]
